The Daily Buyout
UndisclosedMergerHealthcare & Life SciencesCompleted

Zoar completes business combination with Impact Biomedical

Hong Kong-based Zoar Limited, which develops and manufactures complex active pharmaceutical ingredients and intermediates, completed its business combination with Impact Biomedical Inc., Dr Ashleys Nevada Sub Inc. and Zoar Labs Limited. Its ordinary shares are expected to begin trading on NYSE American.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

Following healthcare M&A?

The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.

Free · Unsubscribe anytime

See what you get →